Workshop on the Treatment of Pulmonary Embolism-PE-TRACT, Dr. Akhilesh Sista

Video Transcription

Video Summary

The PE track trial aims to explore treatment options for patients experiencing reduced functional capacity after pulmonary embolism (PE). Funded by the NHLBI, it investigates if catheter-directed therapy plus anticoagulation improves outcomes over just anticoagulation. Enrolling 500 intermediate-risk PE patients, the trial measures outcomes like peak oxygen uptake at three months and NYHA class at 12 months. Catheter-directed therapy includes mechanical thrombectomy or catheter-directed lysis using FDA-approved devices. The goal is to determine if this therapy leads to better cardiopulmonary health post-PE. The trial involves regular interim analyses and patient follow-ups at set intervals.

Keywords

pulmonary embolism

catheter-directed therapy

anticoagulation

cardiopulmonary health

clinical trial